TABLE 1.

Summary of HHV-6A/B strains sequenced in this study

Species	Strain	Cell line	No. of copies/ml			No. of trimmed reads	No. of HHV-6 reads	Unique/DR coverage	Accession no.
			U32	Origin	U95
HHV-6A	GS	HSB2	3.30E9	1.90E10	1.80E9	2,091,792	47,508	54×/36×	MF994822
	GS-early	CBMC	3.30E4	3.40E4		308,104	66,878	60×/37×	KC465951a
	DA	HSB2	2.60E9	2.40E10		3,787,217	30,508	31×/19×	MF994820
	CO-1	HSB2	3.60E9	4.00E10	1.70E9	1,913,207	164,835	165×/107×	MF994815
	CO-2	HSB2	2.60E9	3.20E10	1.00E9	1,278,582	118,403	135×/84×	MF994816
	CO-3	HSB2	5.60E8	5.20E9	2.90E8	896,950	54,464	65×/39×	MF994817
	CO-4	HSB2	5.70E8	6.20E9	5.00E6	6,692,042	42,596	35×/34×	MF994818
	CO-7	HSB2	2.20E8	4.20E9	1.40E6	10,887,157	54,046	43×/42×	MF994819
	SIE	PHA-stimulated CBMC	1.20E10	1.10E10		1,015,200	49,307	63×/36×	MF994828
	ABI-HHV6A (GS)	Unknown	6.41E5	8.98E6		1,644,798	225,145	165×/66×	MF994813
HHV-6B	Z29	SupT1	2.00E6	1.80E7		2,436,488	62,770	90×/52×	MF994829
	HST	MT4	1.10E7	1.50E7		10,666,502	28,251	33×/19×	MF994824
	HST	PHA-stimulated CBMC	1.70E9	1.10E9		1,155,336	29,365	39×/25×	MF994823
	KYO	PHA-stimulated CBMC	7.00E8	8.60E8		949,314	28,626	38×/25×	MF994825
	ENO	PHA-stimulated CBMC	3.30E9	2.00E9		1,116,480	39,004	51×/32×	MF994821
	MAR	PHA-stimulated CBMC	2.30E8	2.70E8		801,650	26,594	34×/21×	MF994826
	NAK	PHA-stimulated CBMC	3.60E6	5.40E6		5,617,132	42,955	44×/33×	MF994827
	ABI-HHV6B (Z29)	Unknown	1.50E5	1.20E6		1,200,052	112,632	104×/100×	MF994814

^aSequenced previously (21); reads received from L. Flamand.